Advertisement
BNGO vs VIVO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and VIVO is a Hold.
BNGO's Indicator enters downward trend
The Aroon Indicator for BNGO entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 321 similar instances where the Aroon Indicator formed such a pattern. In 299 of the 321 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
BNGO moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BNGO crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BNGO's RSI Oscillator exited the oversold zone, 35 of 50 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 66 cases where BNGO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on BNGO as a result. In 67 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in 165 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
BNGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.429) is normal, around the industry mean (4.964). P/E Ratio (-0.382) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for VIVO turns negative, indicating new downward trend
VIVO saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 76 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for VIVO turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 42 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VIVO's RSI Indicator exited the oversold zone, 30 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +30.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 184 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.173) is normal, around the industry mean (16.272). P/E Ratio (-1.036) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
BNGO | VIVO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 72 | 88 | |
P/E GROWTH RATING 1..100 | 100 | 10 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BNGO's Valuation (30) in the Biotechnology industry is significantly better than the same rating for VIVO (96). This means that BNGO’s stock grew significantly faster than VIVO’s over the last 12 months.
BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VIVO (100). This means that BNGO’s stock grew similarly to VIVO’s over the last 12 months.
BNGO's SMR Rating (98) in the Biotechnology industry is in the same range as VIVO (100). This means that BNGO’s stock grew similarly to VIVO’s over the last 12 months.
BNGO's Price Growth Rating (72) in the Biotechnology industry is in the same range as VIVO (88). This means that BNGO’s stock grew similarly to VIVO’s over the last 12 months.
VIVO's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for BNGO (100). This means that VIVO’s stock grew significantly faster than BNGO’s over the last 12 months.
| BNGO | VIVO | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 70% | 3 days ago 81% |
| Stochastic ODDS (%) | 3 days ago 80% | 3 days ago 88% |
| Momentum ODDS (%) | 3 days ago 78% | 3 days ago 90% |
| MACD ODDS (%) | N/A | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 6 days ago 77% | 3 days ago 84% |
| Declines ODDS (%) | 4 days ago 89% | 5 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 80% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BNGO’s FA Score shows that 1 FA rating(s) are green while VIVO’s FA Score has 1 green FA rating(s).
- BNGO’s FA Score: 1 green, 4 red.
- VIVO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BNGO’s TA Score shows that 5 TA indicator(s) are bullish while VIVO’s TA Score has 4 bullish TA indicator(s).
- BNGO’s TA Score: 5 bullish, 4 bearish.
- VIVO’s TA Score: 4 bullish, 5 bearish.
Price Growth
BNGO (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while VIVO (@Computer Communications) price change was -15.50% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.17%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was +12.16%.
The average weekly price growth across all stocks in the @Computer Communications industry was -6.89%. For the same industry, the average monthly price growth was -15.07%, and the average quarterly price growth was -10.08%.
Reported Earning Dates
BNGO is expected to report earnings on Nov 10, 2026.
VIVO is expected to report earnings on Dec 02, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+2.17% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Computer Communications (-6.89% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
Advertisement
BNGO and
Correlation & Price change
A.I.dvisor tells us that BNGO and RGEN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and RGEN's prices will move in lockstep.
| Ticker / NAME | Correlation To BNGO | 1D Price Change % | ||
|---|---|---|---|---|
| BNGO | 100% | +4.55% | ||
| RGEN - BNGO | 30% Poorly correlated | +2.97% | ||
| ARAY - BNGO | 30% Poorly correlated | -11.22% | ||
| PACB - BNGO | 29% Poorly correlated | -7.20% | ||
| VIVO - BNGO | 29% Poorly correlated | +8.74% | ||
| DRIO - BNGO | 28% Poorly correlated | -11.71% | ||
More | ||||
VIVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, VIVO has been loosely correlated with INSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVO jumps, then INSP could also see price increases.
| Ticker / NAME | Correlation To VIVO | 1D Price Change % | ||
|---|---|---|---|---|
| VIVO | 100% | +8.74% | ||
| INSP - VIVO | 41% Loosely correlated | -3.83% | ||
| ICLR - VIVO | 38% Loosely correlated | +1.53% | ||
| BRKR - VIVO | 37% Loosely correlated | +5.60% | ||
| GMED - VIVO | 36% Loosely correlated | -12.76% | ||
| TMO - VIVO | 35% Loosely correlated | +2.63% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FPX | 160.37 | 2.79 | +1.77% |
| First Trust US Equity Opportunities ETF (FPX) | |||
| JAJL | 30.11 | 0.04 | +0.13% |
| Innovator 6mo Jan/Jul (JAJL) | |||
| DWAW | 46.65 | N/A | N/A |
| AdvisorShares Dorsey Wright FSM All Cap World ETF (DWAW) | |||
| QQDN | 22.26 | N/A | N/A |
| ProShares UltraShort Top QQQ | |||
| TEMR | 25.19 | -1.12 | -4.26% |
| T. Rowe Price Emerging Markets Equity Research ETF (TEMR) | |||